Risk scores are statistical indicators based on prescribing patterns compared to specialty peers. They are NOT allegations of fraud, misconduct, or improper care. Many legitimate medical reasons can explain outlier prescribing.
Read our methodology →🤖 ML Fraud Detection Score: Very High
Machine learning model identifies prescribing patterns consistent with confirmed fraud cases. This is a statistical indicator, not an accusation.
Risk Flags
Risk indicators are statistical patterns, not allegations. Learn more
10,518
Total Claims
$677K
Drug Cost
322
Beneficiaries
$2,102
Cost/Patient
Risk Score Breakdown 26/100
Score components are additive. Read full methodology
Peer Comparison vs. 110,156 Internal Medicine providers
+290%
Opioid rate vs peers
8.7% vs 2.2% avg
+49%
Cost per patient vs peers
$2,102 vs $1,411 avg
+4%
Brand preference vs peers
11.1% vs 10.6% avg
⚠️ Opioid + Benzodiazepine Co-Prescriber
This provider prescribes both opioids and benzodiazepines. The FDA has issued a Black Box Warning about the life-threatening risks of concurrent use.
🔎 Data Overview
Our machine learning model — trained on 281 confirmed fraud cases — gives this provider a "Very High" fraud-pattern score. All 20 decision trees in our ensemble model agree that this provider's prescribing patterns resemble those of confirmed fraud cases. This is a statistical finding, not an accusation.
Opioid rate is 290% above Internal Medicine peers. This is a significant deviation that may reflect a specialized patient population or concerning prescribing patterns.
This provider co-prescribes opioids and benzodiazepines — a combination carrying an FDA Black Box Warning due to increased risk of respiratory depression and death. While sometimes clinically necessary, this combination requires careful justification.
Insights generated from CMS data analysis. Statistical patterns are not accusations — always consider clinical context.
Opioid Prescribing
8.7%
Opioid Rate
918
Opioid Claims
$18K
Opioid Cost
3.6%
Long-Acting Rate
Brand vs Generic
Brand: 1,156 claims · $508K
Generic: 9,260 claims · $163K
Top Prescribed Drugs
| Drug (Generic) | Claims | Cost |
|---|---|---|
| Semaglutide | 103 | $131K |
| Apixaban | 91 | $53K |
| Empagliflozin | 73 | $49K |
| Rivaroxaban | 62 | $40K |
| Linaclotide | 65 | $30K |
| Budesonide/Formoterol Fumarate | 53 | $24K |
| Insulin Lispro | 20 | $20K |
| Insulin Glargine,hum.Rec.Anlog | 22 | $18K |
| Dapagliflozin Propanediol | 23 | $18K |
| Hydrocodone/Acetaminophen | 414 | $10K |
| Vigabatrin | 12 | $9,720 |
| Fluticasone Propion/Salmeterol | 12 | $9,469 |
| Sitagliptin Phosphate | 16 | $9,347 |
| Insulin Aspart | 17 | $9,178 |
| Gabapentin | 401 | $8,419 |
Prescribing Profile
Patient Profile
68
Avg Age
53%
Female
1.31
Avg Risk Score
Explore More
Data from CMS Medicare Part D Prescriber Public Use File, 2023. Risk scores are statistical indicators, not allegations.Methodology · About